South America Genome Editing Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)


No. of Pages: 125    |    Report Code: TIPRE00027828    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
South America Genome Editing Market

Market Introduction

Major countries included as a part of analysis for South America includes Argentina, Brazil, and Rest of SAM. The growth of the market for the Genome Editing in the region is attributed to the aging population, flourishing diagnostics market and growing initiatives of the major players in the medical device industry. Furthermore, the prevalence of chronic diseases that demands for promising diagnostic test options is one of the factors that contributes to the growth of the market in the region.

The outbreak of COVID–19 has stringently affected medical services in the South America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is affected by the second wave of corona infection. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is concerned by the emerging new variants of the COVID19 virus. Amongst which Brazil has registered the majority of the deaths. It is anticipated that the region will likely force a restriction of the international travelers, which will ultimately affect the healthcare industry in the area.


Get more information on this report

South America Genome Editing Strategic Insights

Strategic insights for the South America Genome Editing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/south-america-genome-editing-market-strategic-framework.webp
Get more information on this report

South America Genome Editing Report Scope

Report Attribute Details
Market size in 2021 US$ 319.10 Million
Market Size by 2028 US$ 1,003.03 Million
Global CAGR (2021 - 2028) 17.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Technology
  • CRISPR
  • TALEN
  • Antisense
By Application
  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery
By End User
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Clinical Research Organizations
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC INC.
  • MERCK KGaA
  • Lonza
  • Horizon Discovery Group plc.
  • GenScript
  • New England Biolabs
  • Eurofins Scientific
  • CRISPR Therapeutics
  • Get more information on this report

    South America Genome Editing Regional Insights

    The geographic scope of the South America Genome Editing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/south-america-genome-editing-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    The genome editing market in South America is expected to grow US$ 319.10 million in 2021 to US$ 1,003.03 million by 2028; it is estimated to grow at a CAGR of 17.8% from 2021 to 2028. Growing developments in the healthcare industry have led to increasing applications of biotechnology. Also, the growing support from governments, rising public-private partnerships, and increasing funding are widely enhancing the growth of the biotechnologies industry in the region. The value of the biotechnology industry is growing rapidly in the region due to the growing demand for biotechnology products to address changing diseases profile. In addition, the countries in the emerging regions serve vital growth opportunities due to the ever-increasing population and geriatric population. The heavy investments for the development of the healthcare sector have encouraged the adoption of advanced technologies. Moreover, the governments in the region offer tax incentives, cheaper land, incubators, and direct investment that have encouraged the local biotechnology companies to expand their abilities and capacities to contribute to improved healthcare services. This is expected to increase the demand for genome editing and accelerate the market's growth in the coming years.

    Key Market Segments

    In term of technological, CRISPR segment held a larger market share of the genome editing market in 2021. In term of application, genetic engineering segment held a larger market share of the genome editing market in 2021. In term of end user, pharmaceutical and biotechnology companies segment held a larger market share of the genome editing market in 2021.

    Major Sources and Companies Listed

    A few major primary and secondary sources referred to for preparing this report on the genome editing market in South America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are THERMO FISHER SCIENTIFIC INC.; MERCK KGaA; Lonza; Horizon Discovery Group plc.; GenScript; New England Biolabs; Eurofins Scientific; and CRISPR Therapeutics among others.

    Reasons to buy report

    • To understand the South America genome editing market landscape and identify market segments that are most likely to guarantee a strong return
    • Stay ahead of the race by comprehending the ever-changing competitive landscape for South America genome editing market
    • Efficiently plan M&A and partnership deals in South America genome editing market by identifying market segments with the most promising probable sales
    • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South America genome editing market
    • Obtain market revenue forecast for market by various segments from 2021-2028 in South America region.

    South America Genome Editing Market Segmentation

    South America Genome Editing Market – By

    Technology

    • CRISPR
    • TALEN
    • Antisense
    • Other

    South America

    Genome Editing Market – By

    Application

    • Cell Line Engineering
    • Genetic Engineering
    • Diagnostic Applications
    • Drug Discovery
    • Others

    South America

    Genome Editing Market – By

    End User

    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Clinical Research Organizations (CRO's)

    South America

    Genome Editing Market – By

    Country

    • Brazil
    • Argentina
    • Rest of South America

    South America Genome Editing Market – Companies Mentioned

    • THERMO FISHER SCIENTIFIC INC.
    • MERCK KGaA
    • Lonza
    • Horizon Discovery Group plc.            
    • GenScript
    • New England Biolabs
    • Eurofins Scientific
    • CRISPR Therapeutics

    The List of Companies - South America Genome Editing Market

    1. THERMO FISHER SCIENTIFIC INC.
    2. MERCK KGaA
    3. Lonza
    4. Horizon Discovery Group plc.            
    5. GenScript
    6. New England Biolabs
    7. Eurofins Scientific
    8. CRISPR Therapeutics
    Frequently Asked Questions
    How big is the South America Genome Editing Market?

    The South America Genome Editing Market is valued at US$ 319.10 Million in 2021, it is projected to reach US$ 1,003.03 Million by 2028.

    What is the CAGR for South America Genome Editing Market by (2021 - 2028)?

    As per our report South America Genome Editing Market, the market size is valued at US$ 319.10 Million in 2021, projecting it to reach US$ 1,003.03 Million by 2028. This translates to a CAGR of approximately 17.8% during the forecast period.

    What segments are covered in this report?

    The South America Genome Editing Market report typically cover these key segments-

    • Technology (CRISPR, TALEN, Antisense)
    • Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery)
    • End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations)

    What is the historic period, base year, and forecast period taken for South America Genome Editing Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Genome Editing Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South America Genome Editing Market?

    The South America Genome Editing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • THERMO FISHER SCIENTIFIC INC.
  • MERCK KGaA
  • Lonza
  • Horizon Discovery Group plc.
  • GenScript
  • New England Biolabs
  • Eurofins Scientific
  • CRISPR Therapeutics
  • Who should buy this report?

    The South America Genome Editing Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Genome Editing Market value chain can benefit from the information contained in a comprehensive market report.